Sort   by:  
 Page size 
GenomicsMEN1 Mutational Analysis in Hurthle Cell Thyroid Carcinoma - samples
This dataset includes 2 pairs of tumour/normal whole genome sequence data as well as MEN1 gene targeted sequencing of an additional 87 specimens.
EGAD00001001085 | EGA
GenomicsWhole genome study of Hurthle cell thyroid carcinoma
Oncocytic thyroid carcinoma, also known as Hürthle cell thyroid carcinoma, accounts for only a small percentage of all thyroid cancers. However, this malignancy often presents at an advanced stage and poses unique challenges to patients and clinicians. Surgical resection of the tumor accompanied in...
EGAS00001000940 | EGA
GenomicsSNP6_dataset_control - samples
Control samples using SNP Array 6.0
EGAD00010000504 | EGA
Genomicsena-DATASET-BCCA-07-08-2014-18:03:45:054-88 - samples
High-grade serous ovarian cancer (HGSC) is characterized by poor outcome, often attributed to emergence of treatment-resistant sub-clones. We sought to measure the degree of genomic diversity within primary, untreated HGSC to examine the natural state of tumor evolution prior to therapy. We performe...
EGAD00001000974 | EGA
GenomicsSNP6_dataset_case - samples
Case samples using SNP Array 6.0
EGAD00010000502 | EGA
Genomicsena-DATASET-BCCA-13-08-2014-00:21:04:605-267 - samples
Multi-region whole genome sequencing of an high grade serous ovarian carcinoma sample for characterization of genomic intra-tumoural heterogeneity.
EGAD00001000978 | EGA
GenomicsU133_2_dataset_case - samples
Case samples using U133 Plus 2.0 Array
EGAD00010000500 | EGA
Genomicsena-DATASET-BCCA-26-09-2013-17:41:58:095-167 - samples
High-grade serous ovarian cancer (HGSC) is characterized by poor outcome, often attributed to the emergence of treatment-resistant subclones. We sought to measure the degree of genomic diversity within primary, untreated HGSCs to examine the natural state of tumour evolution prior to therapy. We per...
EGAD00001000669 | EGA
GenomicsDistinct evolutionary trajectories of primary high grade serous ovarian cancers revealed through spatial mutational profiling
High-grade serous ovarian cancer (HGSC) is characterized by poor outcome, often attributed to emergence of treatment-resistant sub-clones. We sought to measure the degree of genomic diversity within primary, untreated HGSC to examine the natural state of tumor evolution prior to therapy. We performe...
EGAS00001000547 | EGA
GenomicsEGAD00000000114
Whole transcriptome sequence data from 18 ovarian clear-cell carcinoma samples and one TOV21G ovarian clear-cell carcinoma cell line
EGAD00000000114 | EGA
Sort   by:  
 Page size